Skip to main content
SpringerLink
Log in

Monitoring neuroprotection and restorative therapies in Parkinson’s disease with PET

  • Conference paper
Advances in Research on Neurodegeneration

  • 305 Accesses

Summary

In this article the role of functional imaging (PET and SPECT) as a surrogate marker for following the progression of Parkinson’s disease (PD) is discussed. The potential value of PET and SPECT for assessing the efficacy of putative neuroprotective agents in PD is considered and a review of 18F-dopa PET findings in transplantation trials involving implantation of human and procine fetal mesencephalic tissue is presented. It is concluded that functional imaging provides a valuable adjunct to clinical assessment when judging the efficacy of neuroprotective and restorative approaches to PD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alexander T, Sortwell CE, Sladek CD, Roth RH, Steece-Collier K (1997) Comparison of neurotoxicity following repeated administration of L-dopa, D-dopa, and dopamine to embryonic mesencephalic dopamine neurons in cultures derived from Fischer 344 and Sprague-Dawley donors. Cell Transplant 6: 309-315

    Article  PubMed  CAS  Google Scholar 

  • Banati RB, Goerres GW, Brooks DJ et al (1999a) PK11195 positron emission tomography imaging of activated microglia in Rasmussen’s encephalitis. Neurology 53: 2199-2203

    Article  PubMed  CAS  Google Scholar 

  • Banati R, Cagnin A, Myers R et al (1999b) In vivo detection of activated microglia by ["C]PK11195-PET indicates involvement of the globus pallidum in idiopathic Parkinson’s disease. Parkinsonism Relat Disord 5: S56 (abstr)

    Google Scholar 

  • Brundin P, Pogarel O, Hagell P et al (2000) Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson’s disease. Brain (in press)

    Google Scholar 

  • Ellias SA, Palmer EP, Kott HS et al (1998) Transplantation of fetal porcine ventral mesencephalic cells for treatment of Parkinson’s disease: One year safety and efficacy results. Neurology 50 Suppl 4: A80

    Article  Google Scholar 

  • Fahn S, Elton RL, and members of the UPDRS development committee (1987) Unified Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Goldstein M et al (eds) Recent developments in Parkinson’s disease. Macmillan, New York, 153-163

    Google Scholar 

  • Fearnley JM, Lees AJ (1991) Ageing and Parkinson’s disease: Substantia nigra regional selectivity. Brain 114: 2283-2301

    Article  PubMed  Google Scholar 

  • Freed CR, Breeze RE, Rosenberg NL et al (1992) Survival of implanted fetal dopamine cells and neurologic improvement 12 to 46 months after transplantation for Parkinson’s disease. N Engl J Med 327: 1549-1555

    Article  PubMed  CAS  Google Scholar 

  • Freeman TB, Olanow CW, Hauser RA et al (1995) Bilateral fetal nigral transplantion into the post-commisural putamen as a treatment for Parkinson’s disease: six months follow-up. Ann Neurol 38: 379-388

    Article  PubMed  CAS  Google Scholar 

  • Hagell P, Schrag AE, Piccini P et al (1999) Sequential bilateral transplantation in Parkinson’s disease: Effects of the second graft. Brain 122: 1121-1132

    Article  PubMed  Google Scholar 

  • Hauser RA, Freeman TB, Snow BJ et al (1999) Long-term evaluation of bilateral fetal nigral transplantation in Parkinson disease. Arch Neurol 56: 179-187

    Article  PubMed  CAS  Google Scholar 

  • Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992a) The accuracy of the clinical diagnosis of Parkinson’s disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184

    Article  PubMed  CAS  Google Scholar 

  • Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ (1992b) What features improve the accuracy of clinical diagnosis in Parkinson’s disease: A clinicopathological study. Neurology 42: 1142-1146

    Article  PubMed  CAS  Google Scholar 

  • Jellinger K (1987) The pathology of parkinsonism. In: Marsden CD, Fahn S (eds) Movement disorders 2. Butterworths, London, 33-65

    Google Scholar 

  • Kordower JH, Freeman TB, Snow BJ et al (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson’s disease. N Engl J Med 332: 1118-1124

    Article  PubMed  CAS  Google Scholar 

  • Kordower JH, Freeman TB, Chen EY et al (1998) Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson’s disease. Mov Disord 13: 383-393

    Article  PubMed  CAS  Google Scholar 

  • Kuwabara H, Cumming P, Reith J et al (1993) Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[’8F]fluorodopa and positron emission tomography: Error analysis and application to normal subjects. J Cereb Blood Flow Metab 13: 43-56

    Article  PubMed  CAS  Google Scholar 

  • Lang AE, Benabid AL, Koller WC et al (1995) The Core Assessment Program for intracerebral transplantation. Mov Disord 10: 527-528

    Article  PubMed  CAS  Google Scholar 

  • Langston JW, Widner H, Goetz CG et al (1992) Core assessment program for intracerebral transplantations (CAPIT). Mov Disord 7: 2-13

    Article  PubMed  CAS  Google Scholar 

  • Leber P (1997) Slowing the progression of Alzheimer disease: Methodologic issues. Alzheimer Dis Assoc Disord 11 Suppl 5: S10-S20

    Google Scholar 

  • Louis DE, Tang MX, Cote L, Alfaro B, Mejia H, Marder KM (1999) Progression of parkinsonian signs in Parkinson’s disease. Arch Neurol 56: 334-337

    Article  PubMed  CAS  Google Scholar 

  • Marek KL, Innis RB, Seibyl J (1998) Assessment of Parkinson’s disease progression with 3-CIT and SPECT imaging. Mov Disord 13 Suppl 2: 238 (abstr)

    Google Scholar 

  • Martinez-Martin P, Gil-Nagel A, Gracia LM et al (1994) Unified Parkinson’s disease rating scale: characteristics and structure. Mov Disord 9: 76-83

    Article  PubMed  CAS  Google Scholar 

  • Morrish PK, Sawle GV, Brooks DJ (1995) Clinical and [18F]dopa PET findings in early Parkinson’s disease. J Neurol Neurosurg Psychiatry 59: 597-600

    Article  PubMed  CAS  Google Scholar 

  • Morrish PK, Sawle GV, Brooks DJ (1996) An [18F]dopa PET and clinical study of the rate of progression in Parkinson’s disease. Brain 119: 585-591

    Article  PubMed  Google Scholar 

  • Morrish PK, Rakshi JS, Sawle GV, Brooks DJ (1998) Measuring the rate of progression and estimating the preclinical period of Parkinson’s disease with [18F]dopa PET. J Neurol Neurosurg Psychiatry 64: 314-319

    Article  PubMed  CAS  Google Scholar 

  • Nurmi EM, Ruottinen HM, Bergman J, Haaparanta M, Solin O, Rinne JO (1999) The rate of progression in Parkinson’s disease: A [18F]Dopa PET study. Neurology 52 Suppl 2: A91 (abstr)

    Google Scholar 

  • Olanow CW, Jenner P, Brooks D (1998) Dopamine agonists and neuroprotection in Parkinson’s disease. Ann Neurol 44 Suppl 1: S167-S174

    Google Scholar 

  • Otsuka M, Ichiya Y, Kuwabara Y et al (1996) Differences in the reduced 18F-dopa uptakes of the caudate and the putamen in Parkinson’s disease: Correlations with the three main symptoms. J Neurol Sci 136: 169-173

    Article  PubMed  CAS  Google Scholar 

  • Pate BD, Kawamata T, Yamada T et al (1993) Correlation of striatal fluorodopa uptake in the MPTP monkey with dopaminergic indices. Ann Neurol 34: 331-338

    Article  PubMed  CAS  Google Scholar 

  • Piccini P, Brooks DJ, Bjorklund A et al (1999) Dopamine release from nigral transplants visualised in vivo in a Parkinson’s patient. Nat Neurosci 2: 1137-1140

    Article  PubMed  CAS  Google Scholar 

  • Rakshi JS, Bailey DL, Morrish PK, Brooks DJ (1996) Implementation of 3D acquisition, reconstruction, and analysis of dynamic [18F] Fluorodopa studies. In: Myers R, Cunningham V, Bailey D, Jones T (eds), Quantification of brain function using PET. Academic Press, San Diego, 82-87

    Chapter  Google Scholar 

  • Remy P, Samson Y, Hantraye P et al (1995) Clinical correlates of [18F]fluorodopa uptake in five grafted parkinsonian patients. Ann Neurol 38: 580-588

    Article  PubMed  CAS  Google Scholar 

  • Sawle GV, Colebatch JG, Shah A, Brooks DJ, Marsden CD, Frackowiak RS (1990) Striatal function in normal aging: Implications for Parkinson’s disease. Ann Neurol 28: 799-804.

    Article  PubMed  CAS  Google Scholar 

  • Shoulson I, The Parkinson Study Group (1989) Effect of deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 321: 1364-1371

    Article  Google Scholar 

  • Snow BJ, Tooyama I, McGeer EG et al (1993) Human positron emission tomographic I18F]fluorodopa studies correlate with dopamine cell counts and levels. Ann Neurol 34: 324-330

    Article  PubMed  CAS  Google Scholar 

  • Turjanski N, Lees AJ, Brooks DJ (1999) Striatal dopaminergic receptor dysfunction in patients with restless legs syndrome: 18F-dopa and "C-raclopride PET studies. Neurology 52: 932-937

    Article  PubMed  CAS  Google Scholar 

  • Vingerhoets FJG, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB (1994) Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 36: 759-764

    Article  PubMed  CAS  Google Scholar 

  • Ward CD (1994) Does selegiline delay the progression of Parkinson’s disease? A critical reevaluation of the DATATOP study. J Neurol Neurosurg Psychiatry 57: 217-220

    Article  PubMed  CAS  Google Scholar 

  • Widner H, Tetrud J, Rehncrona S et al (1992) Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6tetrahydropyridine (MPTP). N Engl J Med 327: 1556-1563

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, UK

    D. J. Brooks

Authors
  1. D. J. Brooks
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Psychiatry, University of Würzburg, Federal Republic of Germany

    P. Riederer

  2. Neurodegenerative Disorders Centre, Faculty of Medicine, University Hospital, Vancouver, B.C., Canada

    D. B. Calne

  3. Schering AG Berlin, Berlin, Federal Republic of Germany

    R. Horowski

  4. Department of Neurology, Juntendo University, Tokyo, Japan

    Y. Mizuno

  5. Department of Neurology, Mount Sinai Medical Center, New York, New York, USA

    C. W. Olanow

  6. Department of Neurology, University of Innsbruck, Innsbruck, Austria

    W. Poewe

  7. Department of Pharmacology, Faculty of Medicine, Technion, Haifa, Israel

    M. B. H. Youdim

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Wien

About this paper

Cite this paper

Brooks, D.J. (2000). Monitoring neuroprotection and restorative therapies in Parkinson’s disease with PET. In: Riederer, P., et al. Advances in Research on Neurodegeneration. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6301-6_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6301-6_8

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83537-1

  • Online ISBN: 978-3-7091-6301-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation